The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Phenotype Switching Is a Natural Consequence of Staphylococcus aureus Replication
Open accessAbstract
The pathogen Staphylococcus aureus undergoes phenotype switching in vivo from its normal colony phenotype (NCP) to a slow-growing, antibiotic-resistant small-colony-variant (SCV) phenotype that is associated with persistence in host cells and tissues. However, it is not clear whether phenotype switching is the result of a constitutive process that is selected for under certain conditions or is triggered by particular environmental stimuli. Examination of cultures of diverse S. aureus strains in the absence of selective pressure consistently revealed a small gentamicin-resistant SCV subpopulation that emerged during exponential-phase NCP growth and increased in number until NCP stationary phase. Treatment of replicating bacteria with the antibiotic gentamicin, which inhibited NCP but not SCV replication, resulted in an initial decrease in SCV numbers, demonstrating that SCVs arise as a consequence of NCP replication. However, SCV population expansion in the presence of gentamicin was reestablished by selection of phenotype-stable SCVs and subsequent SCV replication. In the absence of selective pressure, however, phenotype switching was bidirectional and occurred at a high frequency during NCP replication, resulting in SCV turnover. In summary, these data demonstrate that S. aureus phenotype switching occurs via a constitutive mechanism that generates a dynamic, antibiotic-resistant subpopulation of bacteria that can revert to the parental phenotype. The emergence of SCVs can therefore be considered a normal part of the S. aureus life cycle and provides an insurance policy against exposure to antibiotics that would otherwise eliminate the entire population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, SCVs that appeared in the cultures were generated by the acquisition of mutations in wild-type cells (22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we used a previously described stability assay (22) and found that SCVs that arose in cultures exposed to H2O2 or paraquat were significantly more stable than those that arose in broth only (Fig. 4C, D, and E).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
In the citing paper
“Previous work has shown that gentamicin-resistant SCVs emerge in replicating populations in the absence of environmental stress via stochastic mutations but frequently revert to the wild type (WT) via the acquisition of suppressor mutations (15, 17, 22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
In the citing paper
“As reported previously, wild-type S. aureus grew rapidly in the absence of H2O2 and produced a small SCV subpopulation during the early exponential phase (Fig. 2A) (22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
In the citing paper
“Previous work has shown that the tetracycline-resistant strain does not suffer a fitness cost under the conditions used (22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 3×
“Phenotype switching from a normal to a slow-growing or dormant phenotype is a widely employed bet-hedging strategy to insure bacteria against environmental conditions that might otherwise eradicate the entire population (3, 17, 19, 37).”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 3×
“Phenotype switching from a normal to a slow-growing or dormant phenotype is a widely employed bet-hedging strategy to insure bacteria against environmental conditions that might otherwise eradicate the entire population (3, 17, 19, 37).”
BackgroundProctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Horsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K., & Foster, S. J. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5457-5467.2002 · Cited by 699
Mutation as a Stress Response and the Regulation of Evolvability
Galhardo, R. S., Hastings, P. J., & Rosenberg, S. M. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701648502 · Cited by 643 · cited 1×
“While it may seem reasonable to expect mutations to occur during replication, there is convincing evidence that mutation rates increase in stationary phase compared with exponential phase (10, 20, 26, 29).”
BackgroundKussell, E., Kishony, R., Balaban, N. Q., & Leibler, S. (2005) · Genetics · doi:10.1534/genetics.104.035352 · Cited by 584
Staphylococcus aureus: new evidence for intracellular persistence
Garzoni, C., & Kelley, W. L. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.005 · Cited by 474 · cited 1×
“aureus persists within host tissues are poorly understood but likely include both biofilm formation and intracellular residency, both of which confer a degree of protection against immune components and antimicrobial therapy (1, 9, 11, 23, 28).”
BackgroundPersistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437 · cited 4×
“Such auxotrophic phenotypes have been reported previously in clinical samples (5, 13, 15, 30, 31).”
BackgroundInfluentialTuchscherr, L., Medina, E., Hussain, M., Völker, W., Heitmann, V., Niemann, S., Holzinger, D., Roth, J., Proctor, R. A., Becker, K., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000115 · Cited by 437 · cited 2×
“The clinical evidence for a role for SCVs in persistence is supported by a recent animal study that demonstrated the emergence of SCVs and concomitant loss of NCP in tissues (bone and kidney) over time using a persistent infection model (35).”
BackgroundBet-hedging and epigenetic inheritance in bacterial cell development
Veening, J.-W., Stewart, E. J., Berngruber, T. W., Taddei, F., Kuipers, O. P., & Hamoen, L. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700463105 · Cited by 357 · cited 1×
“Phenotype switching from a normal to a slow-growing or dormant phenotype is a widely employed bet-hedging strategy to insure bacteria against environmental conditions that might otherwise eradicate the entire population (3, 17, 19, 37).”
Backgroundvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310 · cited 1×
“To examine the SCV phenotype in vitro and in animal model systems, stable mutants have been constructed to overcome the problem of SCV instability (4, 5, 38).”
MethodSOS Mutator DNA Polymerase IV Functions in Adaptive Mutation and Not Adaptive Amplification
McKenzie, G. J., Lee, P. L., Lombardo, M.-J., Hastings, P. J., & Rosenberg, S. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00204-0 · Cited by 305 · cited 2×
“Work with Escherichia coli indicates that mutations that occur during replication are caused by a different mechanism than mutations that occur in stationary phase (26).”
BackgroundStaphylococcus aureus Small‐Colony Variants Are Adapted Phenotypes for Intracellular Persistence
Tuchscherr, L., Heitmann, V., Hussain, M., Viemann, D., Roth, J., von Eiff, C., Peters, G., Becker, K., & Löffler, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/656047 · Cited by 275 · cited 1×
“The ability of SCVs to persist within host cells is hypothesized to be due to reduced expression of cytolytic toxins via downregulation of the quorum-sensing system Agr, which also results in enhanced expression of surface proteins associated with cell invasion (35, 36).”
BackgroundEvolutionary dynamics of Staphylococcus aureus during progression from carriage to disease
Young, B. C., Golubchik, T., Batty, E. M., Fung, R., Larner-Svensson, H., Votintseva, A. A., Miller, R. R., Godwin, H., Knox, K., Everitt, R. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113219109 · Cited by 273 · cited 1×
“aureus from a commensal into a pathogen (41).”
BackgroundPonder, R. G., Fonville, N. C., & Rosenberg, S. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.07.025 · Cited by 257
Staphylococcus aureus Small Colony Variants in Prosthetic Joint Infection
Sendi, P., Rohrbach, M., Graber, P., Frei, R., Ochsner, P. E., & Zimmerli, W. (2006) · Clinical Infectious Diseases · doi:10.1086/507633 · Cited by 232 · cited 3×
“SCVs are often, but not always, resistant to aminoglycoside antibiotics such as gentamicin and frequently other classes of antimicrobial agents as well (24, 33).”
Backgroundvon Eiff, C., Becker, K., Metze, D., Lubritz, G., Hockmann, J., Schwarz, T., & Peters, G. (2001) · Clinical Infectious Diseases · doi:10.1086/320519 · Cited by 190 · cited 1×
“aureus persistence with a phenotypic shift from the normal colony phenotype (NCP) to a slow-growing small-colony-variant (SCV) phenotype that exhibits reduced pigmentation and hemolysis (21, 30, 31, 33, 39).”
BackgroundIs Staphylococcus aureus an intracellular pathogen?
Lowy, F. D. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01803-5 · Cited by 186 · cited 1×
“aureus persists within host tissues are poorly understood but likely include both biofilm formation and intracellular residency, both of which confer a degree of protection against immune components and antimicrobial therapy (1, 9, 11, 23, 28).”
BackgroundAdaptive immune responses in Staphylococcus aureus biofilm–associated chronic rhinosinusitis
Foreman, A., Holtappels, G., Psaltis, A. J., Jervis-Bardy, J., Field, J., Wormald, P., & Bachert, C. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02678.x · Cited by 159 · cited 1×
“aureus persists within host tissues are poorly understood but likely include both biofilm formation and intracellular residency, both of which confer a degree of protection against immune components and antimicrobial therapy (1, 9, 11, 23, 28).”
BackgroundPersistence: mechanisms for triggering and enhancing phenotypic variability
Balaban, N. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.10.001 · Cited by 156 · cited 1×
“The presence of a subpopulation of non- or slow-growing, antibiotic-tolerant or -resistant cells provides a mechanism for survival and repopulation of a niche in the event that the fast-growing, antibiotic-susceptible population is killed (2, 3, 17, 19).”
BackgroundChatterjee, I., Kriegeskorte, A., Fischer, A., Deiwick, S., Theimann, N., Proctor, R. A., Peters, G., Herrmann, M., & Kahl, B. C. (2007) · Journal of Bacteriology · doi:10.1128/jb.00912-07 · Cited by 145 · cited 3×
“It appears that SCVs arise via mutations, often in genes associated with biosynthetic pathways (5, 7, 18, 31, 32).”
BackgroundPhenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus
Massey, R. C., Buckling, A., & Peacock, S. J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00507-3 · Cited by 141
Plouin‐Gaudon, I., Clément, S., Huggler, E., Chaponnier, C., François, P., Lew, D., Schrenzel, J., Vaudaux, P. E., & Lacroix, J. S. (2006) · PubMed · Cited by 128
Advantage of Upregulation of Succinate Dehydrogenase in Staphylococcus aureus Biofilms
Gaupp, R., Schlag, S., Liebeke, M., Lalk, M., & Götz, F. (2010) · Journal of Bacteriology · doi:10.1128/jb.01472-09 · Cited by 108 · cited 1×
“Furthermore, mutations of other genes have been shown to confer an SCV-like phenotype (12), and it is likely that several other pathways are involved in SCV formation, since SCVs exist with unknown auxotrophisms or for which no molecular basis has been elucidated (13, 15, 32).”
BackgroundLannergård, J., von Eiff, C., Sander, G., Cordes, T., Seggewiβ, J., Peters, G., Proctor, R. A., Becker, K., & Hughes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00668-08 · Cited by 108 · cited 3×
“It appears that SCVs arise via mutations, often in genes associated with biosynthetic pathways (5, 7, 18, 31, 32).”
BackgroundBates, D. M., Eiff, C. V., McNamara, P. J., Peters, G., Yeaman, M. R., Bayer, A. S., & Proctor, R. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374642 · Cited by 106 · cited 1×
“To examine the SCV phenotype in vitro and in animal model systems, stable mutants have been constructed to overcome the problem of SCV instability (4, 5, 38).”
MethodSchaaff, F., Bierbaum, G., Baumert, N., Bartmann, P., & Sahl, H. (2003) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00282 · Cited by 99 · cited 5×
“Furthermore, mutations of other genes have been shown to confer an SCV-like phenotype (12), and it is likely that several other pathways are involved in SCV formation, since SCVs exist with unknown auxotrophisms or for which no molecular basis has been elucidated (13, 15, 32).”
BackgroundInfluentialBesier, S., Ludwig, A., Ohlsen, K., Brade, V., & Wichelhaus, T. A. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.02.003 · Cited by 94 · cited 5×
“To examine the SCV phenotype in vitro and in animal model systems, stable mutants have been constructed to overcome the problem of SCV instability (4, 5, 38).”
BackgroundMethodInfluentialSmall colony variants of Staphylococcus aureus reveal distinct protein profiles
Kriegeskorte, A., König, S., Sander, G., Pirkl, A., Mahabir, E., Proctor, R. A., von Eiff, C., Peters, G., & Becker, K. (2011) · PROTEOMICS · doi:10.1002/pmic.201000796 · Cited by 89 · cited 2×
“The mechanism by which phenotype switching occurs is poorly understood, but SCVs typically arise via mutations that result in the disruption of biosynthetic pathways (5, 7, 16, 18, 31, 32).”
BackgroundBesier, S. M., Zander, J., Kahl, B. C., Kraiczy, P., Brade, V., & Wichelhaus, T. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01395-07 · Cited by 88
High Deleterious Genomic Mutation Rate in Stationary Phase of Escherichia coli
Loewe, L., Textor, V., & Scherer, S. (2003) · Science · doi:10.1126/science.1087911 · Cited by 85 · cited 1×
“While it may seem reasonable to expect mutations to occur during replication, there is convincing evidence that mutation rates increase in stationary phase compared with exponential phase (10, 20, 26, 29).”
BackgroundHigh-frequency transposition for determining antibacterial mode of action
Wang, H., Claveau, D., Vaillancourt, J. P., Roemer, T., & Meredith, T. C. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.643 · Cited by 64 · cited 2×
“aureus RN4220 containing pTM304, which is integrated into the geh locus on the bacterial chromosome, using 85 (40).”
BackgroundMethodSreeramoju, P., Porbandarwalla, N. S., Arango, J. I., Latham, K. P., Dent, D. L., Stewart, R. M., & PATTERSON, J. E. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.12.024 · Cited by 61 · cited 1×
“aureus frequently gives rise to chronic or recurrent infections (8, 22, 27, 30, 33, 34).”
BackgroundGómez-González, C., Acosta, J., Villa, J., Barrado, L., Sanz, F., Orellana, M. Á., Otero, J. R., & Cháves, F. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00520-10 · Cited by 59 · cited 2×
“Such auxotrophic phenotypes have been reported previously in clinical samples (5, 13, 15, 30, 31).”
BackgroundGrowth requirements of some small-colony-forming variants of Staphylococcus aureus
Kaplan, M., & Dye, W. E. (1976) · Journal of Clinical Microbiology · doi:10.1128/jcm.4.4.343-348.1976 · Cited by 45
Small-colony variants of Staphylococcus aureus.
Looney, W. J. (2000) · PubMed · Cited by 40
Molecular Analysis of Repeated Methicillin-Resistant Staphylococcus aureus Infections in Children
Chen, C., Su, L., Lin, T., & Huang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014431 · Cited by 25 · cited 1×
“aureus frequently gives rise to chronic or recurrent infections (8, 22, 27, 30, 33, 34).”
BackgroundMassey, R. C., & Peacock, S. J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01205-8 · Cited by 18
Peyrani, P., Allen, M., Seligson, D., Roberts, C., Chen, A., Haque, N. Z., Zervos, M. J., Wiemken, T. L., Harting, J., Christensen, D. M., et al. (2012) · PubMed · Cited by 16
Cited by
Kahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
“Although SCVs have been described to occur during the normal growth cycle in in vitro studies (28), their occurrence during acute S.”
BackgroundProctor, R. A., Kriegeskorte, A., Kahl, B. C., Becker, K., Löffler, B., & Peters, G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00099 · Cited by 237
“A subset of organisms within many bacterial populations can be part of the normal growth cycle (Lechner et al., 2012), and this is certainly true for S. aureus SCVs, which are part of the normal growth cycle that occurs without any external stresses (Massey et al., 2001; Edwards, 2012).”
BackgroundCollective antibiotic resistance: mechanisms and implications
Vega, N. M., & Gore, J. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.09.003 · Cited by 192
Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Vulin, C., Leimer, N., Huemer, M., Ackermann, M., & Zinkernagel, A. S. (2018) · Nature Communications · doi:10.1038/s41467-018-06527-0 · Cited by 167
Metadata
- Authors
- Edwards, A. M.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Edwards, Andrew M.
- ORCID
- Edwards, Andrew M.
- Venue
- Journal of Bacteriology
- Publisher
- American Society for Microbiology
- Published
- 2012-10
- Volume
- 194
- Issue
- 19
- Pages
- 5404-5412
- ISSN
- 0021-9193 (ISSN-L)
- 1098-5530
- PMC
- PMC3457229
- OpenAlex
- W2083492619
- Cited by
- 83
- References
- 41
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 6 · 2019: 10 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 6 · 2013: 5
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Bacteriology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Imperial College London
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Staphylococcus aureus, small colony variants, phenotypic switching, bacterial replication, antibiotic resistance, gentamicin resistance, bacterial persistence, bidirectional switching, bacterial life cycle
- MeSH terms
- Adaptation, Physiological, Anti-Bacterial Agents, Bacteriological Techniques, Cell Division, Gentamicins, Humans, Microbial Sensitivity Tests, Phenotype, Selection, Genetic, Staphylococcal Infections, Staphylococcus aureus, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.